{
    "2018-03-27": [
        [
            {
                "time": "2018-04-16",
                "original_text": "医药界\"华为\"药明康德过会 中国排名第一全球第十一",
                "features": {
                    "keywords": [
                        "药明康德",
                        "过会",
                        "医药界",
                        "华为"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "药明康德A股IPO上会无悬念过关，常州恐龙园等三公司被否",
                "features": {
                    "keywords": [
                        "药明康德",
                        "A股",
                        "IPO",
                        "过会",
                        "常州恐龙园"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "又一家“独角兽”回归A股 背后影子股值得关注",
                "features": {
                    "keywords": [
                        "独角兽",
                        "回归A股",
                        "影子股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "证监会今日审议6家公司首发申请，仅药明康德绿色动力2家过会",
                "features": {
                    "keywords": [
                        "证监会",
                        "首发申请",
                        "药明康德",
                        "绿色动力"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "环保"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "药明康德50天过会 发行价市盈率或远超23倍",
                "features": {
                    "keywords": [
                        "药明康德",
                        "50天",
                        "过会",
                        "市盈率"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "医药巨头药明康德过会 成第二家快速过会IPO企业",
                "features": {
                    "keywords": [
                        "医药巨头",
                        "药明康德",
                        "过会",
                        "IPO"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "医药界华为药明康德50天火速过会 或成中概股回A首单",
                "features": {
                    "keywords": [
                        "医药界",
                        "华为",
                        "药明康德",
                        "50天",
                        "过会",
                        "中概股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}